• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Chimerix, Inc.

    Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix to Present at H.C. Wainwright 26th Annual Global Investment Conference
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August 13, 2024
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Appoints Marc D. Kozin to Board of Directors
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX UFPT
    Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix to Present at TD Cowen 44th Annual Health Care Conference
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Appoints Lisa Decker to Board of Directors
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix to Participate in Upcoming Investor Conferences
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer
    From Chimerix, Inc.
    Via GlobeNewswire
    Tickers CMRX
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.